Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Pharmaron Beijing Shareholders Equity (Quarterly): 1.595B for March 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 1.595B |
| December 31, 2022 | 1.529B |
| September 30, 2022 | 1.460B |
| June 30, 2022 | 1.515B |
| June 30, 2022 | 1.515B |
| March 31, 2022 | 1.605B |
| December 31, 2021 | 1.589B |
| September 30, 2021 | 1.508B |
| June 30, 2021 | 1.449B |
| June 30, 2021 | 1.449B |
| March 31, 2021 | 1.382B |
| December 31, 2020 | 1.358B |
| September 30, 2020 | 1.240B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.147B |
| June 30, 2020 | 1.147B |
| March 31, 2020 | 1.105B |
| December 31, 2019 | 1.110B |
| September 30, 2019 | 420.34M |
| June 30, 2019 | 411.48M |
| June 30, 2019 | 411.48M |
| March 31, 2019 | 420.45M |
| December 31, 2018 | 336.33M |
| September 30, 2018 | 323.84M |
| June 30, 2018 | 319.03M |
| June 30, 2018 | 319.03M |
| December 31, 2017 | 305.98M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
411.48M
Minimum
Jun 2019
1.605B
Maximum
Mar 2022
1.247B
Average
1.415B
Median
Shareholders Equity (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| Sino Biopharmaceutical Ltd | 4.299B |
| HUTCHMED (China) Ltd | 730.54M |
| Regencell Bioscience Holdings Ltd | 12.03M |
| Prenetics Global Ltd | 206.36M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.058B |
| Total Liabilities (Quarterly) | 1.420B |
| Debt to Equity Ratio | 0.4949 |
| Current Ratio | 1.667 |